Rectify Pharma Stock
Rectify Pharma develops Positive Functional Modulators (PFMs), a class of oral small molecules designed to rectify membrane protein dysfunction that underlies a wide range of serious diseases. Their platform targets specific transporters and channels, focusing on conditions like primary sclerosing cholangitis, chronic kidney disease, and neurodegenerative disorders, offering potential disease-modifying treatments.
Sign up for SecondMarket® to view the market and buy or sell Rectify Pharma Stock
Buy + SellSee Rectify Pharma Valuations + Financials
*Sample data + company shown for illustrative purposes only
Gain insights Into Rectify Pharma Stock Valuation + Share Prices
View real-time Tape D® data on Rectify Pharma stock including most recent valuation and historical share price information.
Are you an institutional investor or employee shareholder? Sign up to the SecondMarket trading platform.
Get StartedRectify Pharma Management Team
-
Board Member
Vikas Goyal
-
Board Member
Jason Rhodes
-
Board Member
Jodie Morrison
-
CEO, President, Board Member
Rajesh Devraj
-
Board Member
Otello Stampacchia
-
Board Member
Tuyen Ong
-
COO
Sachiyo Minegishi
-
Chief Medical Officer
Pol F. Boudes
-
Board Member
Marco Boorsma
-
Chief Business Officer
Bharat Reddy
Learn More About Rectify Pharma Stock
Buy Rectify Pharma Stock
01Rectify Pharma stock does not trade on public stock exchanges. Rectify Pharma stock is considered a private security and you need to be an accredited investor to trade shares. To invest in Rectify Pharma stock you can either buy shares directly through the company or work with a secondary trading marketplace like Nasdaq Private Market.
Learn more about the secondary market for private company shares on the investors page.
Sell Rectify Pharma Stock
02Rectify Pharma Stock does not trade on public stock exchanges. In order to sell Rectify Pharma shares you need to work directly with the company or with a secondary trading marketplace like Nasdaq Private Market. NPM has more than a decade of experience helping sell shares on the private market to our network of institutional investors.
Learn more about NPM services for selling privately held stock on the Employee Shareholders page.
Read more about how to sell private company stock on the private secondary market:
Rectify Pharma Stock Price
03Rectify Pharma does not have a publicly available stock price because it is privately held and not traded on public stock exchanges. Through the Tape D™ database from Nasdaq Private Market, you can view Rectify Pharma share price and other valuable private market data.
Read more about secondary market private company stock prices:
Rectify Pharma Stock Ticker Symbol
04There is no ticker symbol for Rectify Pharma stock because it is a private company. Private companies do not have ticker symbols like public companies, they are identified primarily by using the company ‘street’ name or legal name.
Criteria to Sell Rectify Pharma Stock
05Nasdaq Private Market currently works with employees, ex-employees, and other company investors. In order to sell Rectify Pharma stock you need to receive the company’s approval, which Nasdaq Private Market manages on your behalf.
Learn more about selling privately held stock on the Employee Shareholders page.
Read more about how to sell shares of a private company and eligibility for selling privately held stock:
Criteria to Buy or Invest in Rectify Pharma Stock
06Currently, Nasdaq Private Market only works with accredited entities and institutional investors to purchase private company stock. In order to invest in Rectify Pharma stock, you need to be an accredited entity or institutional investor.
Learn more about the Nasdaq Private Market tool kit for investors on the Investor Trading page.
Rectify Pharma Stock Settlement
07Once you buy or sell, stock share ownership must transfer before funds are wired. With Nasdaq Private Market, clients leverage our patent-pending Transfer and Settlement technology which streamlines and manages transfer activity from match to settlement.
To learn more about private company stock Transfer and Settlement, check out the Transfer and Settlement page.
Rectify Pharma IPO
08Rectify Pharma is a private company and has not had an IPO. There is currently no Rectify Pharma IPO price. Get started to begin exploring the Nasdaq Private Market Tape D™ database and gain access to actionable data related to Rectify Pharma IPO.
Learn more about Tape D™ private company stock data for institutional investors on the on the Tape D™ Product Page.
Sign up for SecondMarket® to view the market and buy or sell Rectify Pharma Stock
Buy + Sell*All trademarks are the property of their respective owner(s). Unless expressly stated otherwise, companies listed on this site are not sponsoring, endorsing, or otherwise affiliated with, Nasdaq Private Market, LLC, and none of the statements on this website should be attributed to a listed company.